Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melissa L. Comstock"'
Autor:
George S. Laszlo, Johnnie J. Orozco, Allie R. Kehret, Margaret C. Lunn, Jenny Huo, Donald K. Hamlin, D. Scott Wilbur, Shannon L. Dexter, Melissa L. Comstock, Shyril O’Steen, Brenda M. Sandmaier, Damian J. Green, Roland B. Walter
Publikováno v:
Leukemia. 36:1485-1491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca98e249d4e618e00b0d577cbc83be3f
https://doi.org/10.1038/s41375-022-01580-7
https://doi.org/10.1038/s41375-022-01580-7
Autor:
George S, Laszlo, Johnnie J, Orozco, Allie R, Kehret, Margaret C, Lunn, Jenny, Huo, Donald K, Hamlin, D, Scott Wilbur, Shannon L, Dexter, Melissa L, Comstock, Shyril, O'Steen, Brenda M, Sandmaier, Damian J, Green, Roland B, Walter
Publikováno v:
Leukemia. 36(6)
Radioimmunotherapy (RIT) has long been pursued to improve outcomes in acute leukemia and higher-risk myelodysplastic syndrome (MDS). Of increasing interest are alpha-particle-emitting radionuclides such as astatine-211 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ffd56b08b3f91f43d65f18a3b4683dc
https://pubmed.ncbi.nlm.nih.gov/35474099
https://pubmed.ncbi.nlm.nih.gov/35474099
Autor:
Stanley R. Riddell, Damian J. Green, Gabriel O. Cole, Qian Wu, Alexander I. Salter, Brent L. Wood, Lingfeng Liu, Margot J. Pont, Michael Hudecek, Tyler Hill, Jessica Kelliher, Jenna M. Voutsinas, Andrew J. Cowan, Anusha Rajan, Melissa L. Comstock, Bharvin K. R. Patel, Joe J. Abbott
Publikováno v:
Blood
B-cell maturation antigen (BCMA) is a validated target for chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM). Despite promising objective response rates, most patients relapse, and low levels of BCMA on a subset of tumor cells h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3dbc4ec186dee74dbe3a96179084c09
https://doi.org/10.1182/blood.2019000050
https://doi.org/10.1182/blood.2019000050
Autor:
Yukang Lin, Johnnie J. Orozco, Donald K. Hamlin, Brenda M. Sandmaier, Ted Gooley, Sherilyn A. Tuazon, Aimee L. Kenoyer, Margaret E. Nartea, Jon C. Jones, Ajay K. Gopal, Shyril O'Steen, Oliver W. Press, Brian W. Miller, Brian G. Till, D. Scott Wilbur, Damian J. Green, Melissa L. Comstock
Publikováno v:
Blood
Minimal residual disease (MRD) has become an increasingly prevalent and important entity in multiple myeloma (MM). Despite deepening responses to frontline therapy, roughly 75% of MM patients never become MRD-negative to ≤10(−5), which is concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91312884cd9ec7cf086f4e4ae5c7b51a
https://doi.org/10.1182/blood.2019001250
https://doi.org/10.1182/blood.2019001250
Autor:
Cristina R. Antonescu, James P. Scott-Browne, Brian P. Rubin, Yansong Gu, Munir R. Tanas, Jessica Woodell, Melissa L. Comstock, Carol B. Ware
Publikováno v:
Cancer research. 65(15)
A mouse model of gastrointestinal stromal tumor (GIST) has been developed by a knock-in gene targeting strategy, which introduced a Kit gene K641E mutation, originally identified in sporadic human GISTs and in the germ line of familial GIST syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d7f2a538bd21fdb5a927ab80df680c
https://pubmed.ncbi.nlm.nih.gov/16061643
https://pubmed.ncbi.nlm.nih.gov/16061643